Mirae Asset Global Investments Co., Ltd. Biogen Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 35,195 shares of BIIB stock, worth $6.95 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
35,195
Previous 154,328
77.19%
Holding current value
$6.95 Million
Previous $33.3 Million
75.48%
% of portfolio
0.04%
Previous 0.06%
Shares
29 transactions
Others Institutions Holding BIIB
# of Institutions
1,050Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.28 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.23 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.87 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.4 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.12 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $28.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...